Clinical Evaluation of Naqooh Shahtara in the Management of Type 2 Diabetes Mellitus

Authors

  • Adnan Mastan
  • Naseem Akhtar Khan

Abstract

Diabetes is a major public health problem and considered as one of the most common non-communicable disease, globally. Although the prevalence rate of the disease varies country to country. However, WHO has projected India as the country with the fastest growing population of diabetes patients. Due to its consequences diabetes has become a silent killer that kills one person every 10 seconds, and worldwide it kills 3.2 million every year. In Unani System of Medicine Diabetes is known by the name Ziabetus. Unani physician have been treating diabetes since ancient times; they have described a number of Unani drugs both single and compound for the management of diabetes. The present study was aimed to evaluate the efficacy of Naqooh Shahtara in the treatment of type 2 diabetes mellitus. The patients were given test drug orally in the form of Naqooh once daily 15 minutes before the breakfast for 60 days. The study showed good response on blood sugar level of the cases treated with Unani formulation without any apparent side effects.

Keywords: Ziabetus, type 2 diabetes mellitus, Naqooh Shahtara

Cite this Article

Adnan Mastan, Naseem Akhtar Khan. Clinical Evaluation of Naqooh Shahtara in the Management of Type 2 Diabetes Mellitus.Journal of AYUSH: Ayurveda, Yoga, Unani, Siddha and Homeopathy. 2016, 5(1): 32–37p.


 

Author Biography

  • Adnan Mastan
    I am a dedicated researcher in the field of Unani Medicine, completed BUMS, MD (Medicine) from A & U Tibbia College, Karol Bagh, New Delhi. Currently working as Research Associate in Central Council for Research in Unani Medicine, New Delhi under Ministry of AYUSH.

Downloads

Published

2016-05-19

Issue

Vol. 5 No. 1 (2016)

Section

Research/Review Articles

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is notpublished already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  • I/We also agree to the authorship of the article in the following order:

Author’s name

 

1. ________________

2. ________________

3. ________________

_______________

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.